Z-1747-2025 Class II Ongoing

Recalled by Foundation Medicine, Inc. — Cambridge, MA

FDA device recall Z-1747-2025 was initiated by Foundation Medicine, Inc. on Apr 9, 2025 and is designated Class II. Reason for recall: Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling… The recall status is ongoing. Affected quantity: 4 units.

Recall Details

Product Type
Devices
Report Date
May 21, 2025
Initiation Date
Apr 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 units

Product Description

FoundationOne Companion Diagnostic (F1CDx)

Reason for Recall

Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.

Code Information

ORD-XXXXX28-01 ORD-XXXXX98-01 ORD-XXXXX29-01 ORD-XXXXX99-01 Note: The above characters have been redacted to minimize patient information disclosure.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1747-2025
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1747-2025. Report a data issue: hello@regdatalab.com.